메뉴 건너뛰기




Volumn 9, Issue , 2015, Pages 241-272

Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells

Author keywords

Akt; Alzheimer's disease; A oligomer; Caffeine; Chronotherapy; Coffee; Melatonin; Nrf2; Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA CATENIN; CAFFEINE; GAMMA INTERFERON; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P55; REACTIVE OXYGEN METABOLITE; TAU PROTEIN; TRANSCRIPTION FACTOR NRF2; WNT3A PROTEIN; COFFEE;

EID: 84920106977     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S71106     Document Type: Article
Times cited : (26)

References (112)
  • 2
  • 3
    • 84893790299 scopus 로고    scopus 로고
    • Alzheimer’s disease: Charting the crossroads between neurology and psychology
    • Gilbert T, Herbst M. Alzheimer’s disease: charting the crossroads between neurology and psychology. J Neurol Neurosurg Psychiatry. 2014;85(2):133–134.
    • (2014) J Neurol Neurosurg Psychiatry , vol.85 , Issue.2 , pp. 133-134
    • Gilbert, T.1    Herbst, M.2
  • 4
    • 84897954407 scopus 로고    scopus 로고
    • Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
    • Reitz C, Mayeux R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol. 2014;88(4): 640–651.
    • (2014) Biochem Pharmacol , vol.88 , Issue.4 , pp. 640-651
    • Reitz, C.1    Mayeux, R.2
  • 5
    • 29144508843 scopus 로고    scopus 로고
    • Alzheimer’s Disease International. Global prevalence of dementia: A Delphi consensus study
    • Ferri CP, Prince M, Brayne C, et al; Alzheimer’s Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005; 366(9503):2112–2117.
    • (2005) Lancet , vol.366 , Issue.9503 , pp. 2112-2117
    • Ferri, C.P.1    Prince, M.2    Brayne, C.3
  • 6
    • 84897481309 scopus 로고    scopus 로고
    • Alzheimer’s Association report
    • Fargo K, Bleiler L. Alzheimer’s Association report. Alzheimers Dement. 2014;10(2):e47–e92.
    • (2014) Alzheimers Dement , vol.10 , Issue.2 , pp. e47-e92
    • Fargo, K.1    Bleiler, L.2
  • 7
    • 84878660799 scopus 로고    scopus 로고
    • Global Health Epidemiology Reference Group (GHERG). Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990–2010: A systematic review and analysis
    • Chan KY, Wang W, Wu JJ, et al; Global Health Epidemiology Reference Group (GHERG). Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990–2010: a systematic review and analysis. Lancet. 2013;381(9882):2016–2023.
    • (2013) Lancet , vol.381 , Issue.9882 , pp. 2016-2023
    • Chan, K.Y.1    Wang, W.2    Wu, J.J.3
  • 8
    • 84897519875 scopus 로고    scopus 로고
    • Deaths in the United States among persons with Alzheimer’s disease (2010–2050)
    • Weuve J, Hebert LE, Scherr PA, Evans DA. Deaths in the United States among persons with Alzheimer’s disease (2010–2050). Alzheimers Dement. 2014;10(2):e40–e46.
    • (2014) Alzheimers Dement , vol.10 , Issue.2 , pp. e40-e46
    • Weuve, J.1    Hebert, L.E.2    Scherr, P.A.3    Evans, D.A.4
  • 9
    • 84871036375 scopus 로고    scopus 로고
    • Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010
    • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128.
    • (2012) Lancet , vol.380 , Issue.9859 , pp. 2095-2128
    • Lozano, R.1    Naghavi, M.2    Foreman, K.3
  • 10
    • 84862253313 scopus 로고    scopus 로고
    • Number of people with dementia will reach 65.7 million by 2030, says report
    • Gulland A. Number of people with dementia will reach 65.7 million by 2030, says report. BMJ. 2012;344:e2604.
    • (2012) BMJ , vol.344
    • Gulland, A.1
  • 11
    • 84872119357 scopus 로고    scopus 로고
    • Alzheimer Disease International. The worldwide economic impact of dementia 2010
    • Wimo A, Jönsson L, Bond J, Prince M, Winblad B; Alzheimer Disease International. The worldwide economic impact of dementia 2010. Alzheimers Dement. 2013;9(1):1–11.e3.
    • (2013) Alzheimers Dement , vol.9 , Issue.1 , pp. 1-11.e3
    • Wimo, A.1    Jönsson, L.2    Bond, J.3    Prince, M.4    Winblad, B.5
  • 12
    • 77949335521 scopus 로고    scopus 로고
    • The worldwide societal costs of dementia: Estimates for 2009
    • Wimo A, Winblad B, Jönsson L. The worldwide societal costs of dementia: Estimates for 2009. Alzheimers Dement. 2010;6(2): 98–103.
    • (2010) Alzheimers Dement , vol.6 , Issue.2 , pp. 98-103
    • Wimo, A.1    Winblad, B.2    Jönsson, L.3
  • 13
    • 78751644048 scopus 로고    scopus 로고
    • Amyloid-βand Tau – a toxic pas de deux in Alzheimer’s disease
    • Ittner LM, Götz J. Amyloid-β and Tau – a toxic pas de deux in Alzheimer’s disease. Nat Rev Neurosci. 2011;12(2):65–72.
    • (2011) Nat Rev Neurosci , vol.12 , Issue.2 , pp. 65-72
    • Ittner, L.M.1    Götz, J.2
  • 14
    • 77955328980 scopus 로고    scopus 로고
    • Fyn-Tau-amyloid: A toxic triad
    • Haass C, Mandelkow E. Fyn-Tau-amyloid: a toxic triad. Cell. 2010; 142(3):356–358.
    • (2010) Cell , vol.142 , Issue.3 , pp. 356-358
    • Haass, C.1    Mandelkow, E.2
  • 15
    • 84863337843 scopus 로고    scopus 로고
    • Alzheimer mechanisms and therapeutic strategies
    • Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2012;148(6):1204–1222.
    • (2012) Cell , vol.148 , Issue.6 , pp. 1204-1222
    • Huang, Y.1    Mucke, L.2
  • 16
    • 84880516637 scopus 로고    scopus 로고
    • SnapShot: Pathobiology of Alzheimer’s disease
    • Selkoe DJ. SnapShot: pathobiology of Alzheimer’s disease. Cell. 2013; 154(2):468–468.e1.
    • (2013) Cell , vol.154 , Issue.2 , pp. 468-468.e1
    • Selkoe, D.J.1
  • 17
    • 84899019792 scopus 로고    scopus 로고
    • Amyloid-βand Tau: The trigger and bullet in Alzheimer disease pathogenesis
    • Bloom GS. Amyloid-β and Tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71(4):505–508.
    • (2014) JAMA Neurol , vol.71 , Issue.4 , pp. 505-508
    • Bloom, G.S.1
  • 18
    • 84655166490 scopus 로고    scopus 로고
    • Identification and biology of β-secretase
    • Kandalepas PC, Vassar R. Identification and biology of β-secretase. J Neurochem. 2012;120 Suppl 1:S55–S61.
    • (2012) J Neurochem , vol.120 , pp. S55-S61
    • Kandalepas, P.C.1    Vassar, R.2
  • 19
    • 84876014912 scopus 로고    scopus 로고
    • Shen Y. β-Secretase: Its biology as a therapeutic target in diseases
    • Wang H, Li R, Shen Y. β-Secretase: its biology as a therapeutic target in diseases. Trends Pharmacol Sci. 2013;34(4):215–225.
    • (2013) Trends Pharmacol Sci , vol.34 , Issue.4 , pp. 215-225
    • Wang, H.1    Li, R.2
  • 20
    • 84894090892 scopus 로고    scopus 로고
    • Targeting the β secretase BACE1 for Alzheimer’s disease therapy
    • Yan R, Vassar R. Targeting the β secretase BACE1 for Alzheimer’s disease therapy. Lancet Neurol. 2014;13(3):319–329.
    • (2014) Lancet Neurol , vol.13 , Issue.3 , pp. 319-329
    • Yan, R.1    Vassar, R.2
  • 21
    • 84892710970 scopus 로고    scopus 로고
    • Antiamyloid therapy for Alzheimer’s disease – are we on the right road?
    • Karran E, Hardy J. Antiamyloid therapy for Alzheimer’s disease – are we on the right road? N Engl J Med. 2014;370(4):377–378.
    • (2014) N Engl J Med , vol.370 , Issue.4 , pp. 377-378
    • Karran, E.1    Hardy, J.2
  • 22
    • 84884255356 scopus 로고    scopus 로고
    • A template for new drugs against Alzheimer’s disease
    • Aguzzi A, Gitler AD. A template for new drugs against Alzheimer’s disease. Cell. 2013;154(6):1182–1184.
    • (2013) Cell , vol.154 , Issue.6 , pp. 1182-1184
    • Aguzzi, A.1    Gitler, A.D.2
  • 23
    • 84873026509 scopus 로고    scopus 로고
    • Toward the treatment and prevention of Alzheimer’s disease: Rational strategies and recent progress
    • Gandy S, DeKosky ST. Toward the treatment and prevention of Alzheimer’s disease: rational strategies and recent progress. Annu Rev Med. 2013;64:367–383.
    • (2013) Annu Rev Med , vol.64 , pp. 367-383
    • Gandy, S.1    Dekosky, S.T.2
  • 24
    • 79953245971 scopus 로고    scopus 로고
    • Coffee and its consumption: Benefits and risks
    • Butt MS, Sultan MT. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2011;51(4):363–373.
    • (2011) Crit Rev Food Sci Nutr , vol.51 , Issue.4 , pp. 363-373
    • Butt, M.S.1    Sultan, M.T.2
  • 25
    • 77956195598 scopus 로고    scopus 로고
    • Caffeine, diabetes, cognition, and dementia
    • Biessels GJ. Caffeine, diabetes, cognition, and dementia. J Alzheimers Dis. 2010;20 Suppl 1:S143–S150.
    • (2010) J Alzheimers Dis , vol.20 , pp. S143-S150
    • Biessels, G.J.1
  • 28
    • 27644449587 scopus 로고    scopus 로고
    • Functional MT1 and MT2 melatonin receptors in mammals
    • Dubocovich ML, Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine. 2005;27(2):101–110.
    • (2005) Endocrine , vol.27 , Issue.2 , pp. 101-110
    • Dubocovich, M.L.1    Markowska, M.2
  • 29
    • 0032901972 scopus 로고    scopus 로고
    • Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer’s disease, and apolipoprotein E-epsilon4/4 genotype
    • Liu RY, Zhou JN, van Heerikhuize J, Hofman MA, Swaab DF. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer’s disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab. 1999;84(1):323–327.
    • (1999) J Clin Endocrinol Metab , vol.84 , Issue.1 , pp. 323-327
    • Liu, R.Y.1    Zhou, J.N.2    Van Heerikhuize, J.3    Hofman, M.A.4    Swaab, D.F.5
  • 30
    • 84890495142 scopus 로고    scopus 로고
    • Circadian misalignment and sleep disruption in mild cognitive impairment
    • Naismith SL, Hickie IB, Terpening Z, et al. Circadian misalignment and sleep disruption in mild cognitive impairment. J Alzheimers Dis. 2014;38(4):857–866.
    • (2014) J Alzheimers Dis , vol.38 , Issue.4 , pp. 857-866
    • Naismith, S.L.1    Hickie, I.B.2    Terpening, Z.3
  • 31
    • 84898816454 scopus 로고    scopus 로고
    • Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer’s disease
    • Carman AJ, Dacks PA, Lane RF, Shineman DW, Fillit HM. Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer’s disease. J Nutr Health Aging. 2014;18(4): 383–392.
    • (2014) J Nutr Health Aging , vol.18 , Issue.4 , pp. 383-392
    • Carman, A.J.1    Dacks, P.A.2    Lane, R.F.3    Shineman, D.W.4    Fillit, H.M.5
  • 32
    • 77956195944 scopus 로고    scopus 로고
    • Caffeine and coffee as therapeutics against Alzheimer’s disease
    • Arendash GW, Cao C. Caffeine and coffee as therapeutics against Alzheimer’s disease. J Alzheimers Dis. 2010;20 Suppl 1:S117–S126.
    • (2010) J Alzheimers Dis , vol.20 , pp. S117-S126
    • Arendash, G.W.1    Cao, C.2
  • 33
    • 33750984544 scopus 로고    scopus 로고
    • Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain beta-amyloid production
    • Arendash GW, Schleif W, Rezai-Zadeh K, et al. Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience. 2006;142(4):941–952.
    • (2006) Neuroscience , vol.142 , Issue.4 , pp. 941-952
    • Arendash, G.W.1    Schleif, W.2    Rezai-Zadeh, K.3
  • 34
    • 72449208698 scopus 로고    scopus 로고
    • Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway
    • Canas PM, Porciúncula LO, Cunha GM, et al. Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J Neurosci. 2009;29(47):14741–14751.
    • (2009) J Neurosci , vol.29 , Issue.47 , pp. 14741-14751
    • Canas, P.M.1    Porciúncula, L.O.2    Cunha, G.M.3
  • 35
    • 79956272790 scopus 로고    scopus 로고
    • Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer’s transgenic mice and normal mice: A mechanism for electromagnetic field-induced cognitive benefit?
    • Dragicevic N, Bradshaw PC, Mamcarz M, et al. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer’s transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit? Neuroscience. 2011; 185:135–149.
    • (2011) Neuroscience , vol.185 , pp. 135-149
    • Dragicevic, N.1    Bradshaw, P.C.2    Mamcarz, M.3
  • 36
    • 84862869928 scopus 로고    scopus 로고
    • High Blood caffeine levels in MCI linked to lack of progression to dementia
    • Cao C, Loewenstein DA, Lin X, et al. High Blood caffeine levels in MCI linked to lack of progression to dementia. J Alzheimers Dis. 2012;30(3): 559–572.
    • (2012) J Alzheimers Dis , vol.30 , Issue.3 , pp. 559-572
    • Cao, C.1    Loewenstein, D.A.2    Lin, X.3
  • 37
    • 79960742203 scopus 로고    scopus 로고
    • Caffeine synergizes with another coffee component to increase plasma GCSF: Linkage to cognitive benefits in Alzheimer’s mice
    • Cao C, Wang L, Lin X, et al. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer’s mice. J Alzheimers Dis. 2011;25(2):323–335.
    • (2011) J Alzheimers Dis , vol.25 , Issue.2 , pp. 323-335
    • Cao, C.1    Wang, L.2    Lin, X.3
  • 38
    • 78549290673 scopus 로고    scopus 로고
    • Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer disease
    • He H, Dong W, Huang F. Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer disease. Curr Neuropharmacol. 2010;8(3): 211–217.
    • (2010) Curr Neuropharmacol , vol.8 , Issue.3 , pp. 211-217
    • He, H.1    Dong, W.2    Huang, F.3
  • 39
    • 0032909996 scopus 로고    scopus 로고
    • Melatonin affects the metabolism of the beta-amyloid precursor protein in different cell types
    • Lahiri DK. Melatonin affects the metabolism of the beta-amyloid precursor protein in different cell types. J Pineal Res. 1999;26(3): 137–146.
    • (1999) J Pineal Res , vol.26 , Issue.3 , pp. 137-146
    • Lahiri, D.K.1
  • 40
    • 77951889295 scopus 로고    scopus 로고
    • The mammalian circadian timing system: Organization and coordination of central and peripheral clocks
    • Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 2010;72:517–549.
    • (2010) Annu Rev Physiol , vol.72 , pp. 517-549
    • Dibner, C.1    Schibler, U.2    Albrecht, U.3
  • 41
    • 33847075354 scopus 로고    scopus 로고
    • Circadian rhythms: Mechanisms and therapeutic implications
    • Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol. 2007;47:593–628.
    • (2007) Annu Rev Pharmacol Toxicol , vol.47 , pp. 593-628
    • Levi, F.1    Schibler, U.2
  • 42
    • 0037194790 scopus 로고    scopus 로고
    • Coordination of circadian timing in mammals
    • Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature. 2002;418(6901):935–941.
    • (2002) Nature , vol.418 , Issue.6901 , pp. 935-941
    • Reppert, S.M.1    Weaver, D.R.2
  • 44
    • 84878617961 scopus 로고    scopus 로고
    • Chronotherapy improves blood pressure control and reduces vascular risk in CKD
    • Hermida RC, Ayala DE, Smolensky MH, et al. Chronotherapy improves blood pressure control and reduces vascular risk in CKD. Nat Rev Nephrol. 2013;9(6):358–368.
    • (2013) Nat Rev Nephrol , vol.9 , Issue.6 , pp. 358-368
    • Hermida, R.C.1    Ayala, R.2    Smolensky, M.H.3
  • 45
    • 70450239457 scopus 로고    scopus 로고
    • Metabolism and cancer: The circadian clock connection
    • Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nat Rev Cancer. 2009;9(12):886–896.
    • (2009) Nat Rev Cancer , vol.9 , Issue.12 , pp. 886-896
    • Sahar, S.1    Sassone-Corsi, P.2
  • 46
    • 84882270256 scopus 로고    scopus 로고
    • The circadian system in Alzheimer’s disease: Disturbances, mechanisms, and opportunities
    • Coogan AN, Schutová B, Husung S, et al. The circadian system in Alzheimer’s disease: disturbances, mechanisms, and opportunities. Biol Psychiatry. 2013;74(5):333–339.
    • (2013) Biol Psychiatry , vol.74 , Issue.5 , pp. 333-339
    • Coogan, A.N.1    Schutová, B.2    Husung, S.3
  • 47
    • 84878326836 scopus 로고    scopus 로고
    • Timing is important in medication administration: A timely review of chronotherapy research
    • Kaur G, Phillips C, Wong K, Saini B. Timing is important in medication administration: a timely review of chronotherapy research. Int J Clin Pharm. 2013;35(3):344–358.
    • (2013) Int J Clin Pharm , vol.35 , Issue.3 , pp. 344-358
    • Kaur, G.1    Phillips, C.2    Wong, K.3    Saini, B.4
  • 49
    • 84890803688 scopus 로고    scopus 로고
    • Autophagy and apoptosis dysfunction in neurodegenerative disorders
    • Ghavami S, Shojaei S, Yeganeh B, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112: 24–49.
    • (2014) Prog Neurobiol , vol.112 , pp. 24-49
    • Ghavami, S.1    Shojaei, S.2    Yeganeh, B.3
  • 50
    • 84893714992 scopus 로고    scopus 로고
    • Autophagy in aging and neurodegenerative diseases: Implications for pathogenesis and therapy
    • Tan CC, Yu JT, Tan MS, Jiang T, Zhu XC, Tan L. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy. Neurobiol Aging. 2014;35(5):941–957.
    • (2014) Neurobiol Aging , vol.35 , Issue.5 , pp. 941-957
    • Tan, C.C.1    Yu, J.T.2    Tan, M.S.3    Jiang, T.4    Zhu, X.C.5    Tan, L.6
  • 51
    • 84927574888 scopus 로고    scopus 로고
    • Prediction of the likelihood of drug interactions with kinase inhibitors based on in vitro and computational studies
    • Wang ZX, Sun J, Howell CE, et al. Prediction of the likelihood of drug interactions with kinase inhibitors based on in vitro and computational studies. Fundam Clin Pharmacol. 2014;28(5):551–582.
    • (2014) Fundam Clin Pharmacol , vol.28 , Issue.5 , pp. 551-582
    • Wang, Z.X.1    Sun, J.2    Howell, C.E.3
  • 52
    • 79952941784 scopus 로고    scopus 로고
    • Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study
    • Liu YH, Mo SL, Bi HC, et al. Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study. Xenobiotica. 2011;41(4):259–280.
    • (2011) Xenobiotica , vol.41 , Issue.4 , pp. 259-280
    • Liu, Y.H.1    Mo, S.L.2    Bi, H.C.3
  • 53
    • 84863246281 scopus 로고    scopus 로고
    • Ligand- and protein-based modeling studies of the inhibitors of human cytochrome P450 2D6 and a virtual screening for potential inhibitors from the Chinese herbal medicine, Scutellaria baicalensis (Huangqin, Baikal Skullcap)
    • Mo SL, Liu WF, Chen Y, et al. Ligand- and protein-based modeling studies of the inhibitors of human cytochrome P450 2D6 and a virtual screening for potential inhibitors from the Chinese herbal medicine, Scutellaria baicalensis (Huangqin, Baikal Skullcap). Comb Chem High Throughput Screen. 2012;15(1):36–80.
    • (2012) Comb Chem High Throughput Screen , vol.15 , Issue.1 , pp. 36-80
    • Mo, S.L.1    Liu, W.F.2    Chen, Y.3
  • 54
    • 84863549072 scopus 로고    scopus 로고
    • Pharmacophore, QSAR, and binding mode studies of substrates of human cytochrome P450 2D6 (CYP2D6) using molecular docking and virtual mutations and an application to Chinese herbal medicine screening
    • Mo SL, Liu WF, Li CG, et al. Pharmacophore, QSAR, and binding mode studies of substrates of human cytochrome P450 2D6 (CYP2D6) using molecular docking and virtual mutations and an application to Chinese herbal medicine screening. Curr Pharm Biotechnol. 2012;13(9): 1640–1704.
    • (2012) Curr Pharm Biotechnol , vol.13 , Issue.9 , pp. 1640-1704
    • Mo, S.L.1    Liu, W.F.2    Li, C.G.3
  • 55
    • 84863049413 scopus 로고    scopus 로고
    • Computational and in vitro studies on the inhibitory effects of herbal compounds on human cytochrome P450 1A2
    • Yang LP, Zhou ZW, Chen XW, et al. Computational and in vitro studies on the inhibitory effects of herbal compounds on human cytochrome P450 1A2. Xenobiotica. 2012;42(3):238–255.
    • (2012) Xenobiotica , vol.42 , Issue.3 , pp. 238-255
    • Yang, L.P.1    Zhou, Z.W.2    Chen, X.W.3
  • 56
    • 31844439888 scopus 로고    scopus 로고
    • Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and Tau phosphorylation in vivo and in vitro
    • Ma QL, Lim GP, Harris-White ME, et al. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and Tau phosphorylation in vivo and in vitro. J Neurosci Res. 2006;83(3):374–384.
    • (2006) J Neurosci Res , vol.83 , Issue.3 , pp. 374-384
    • Ma, Q.L.1    Lim, G.P.2    Harris-White, G.3
  • 57
    • 36749078121 scopus 로고    scopus 로고
    • Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers
    • Kayed R, Head E, Sarsoza F, et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener. 2007;2:18.
    • (2007) Mol Neurodegener , vol.2 , pp. 18
    • Kayed, R.1    Head, E.2    Sarsoza, F.3
  • 58
    • 84880945264 scopus 로고    scopus 로고
    • Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease
    • Saido TC. Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease. Proc Jpn Acad Ser B Phys Biol Sci. 2013;89(7): 321–339.
    • (2013) Proc Jpn Acad Ser B Phys Biol Sci , vol.89 , Issue.7 , pp. 321-339
    • Saido, T.C.1
  • 59
    • 78650678688 scopus 로고    scopus 로고
    • Decreased clearance of CNS beta-amyloid in Alzheimer’s disease
    • Mawuenyega KG, Sigurdson W, Ovod V, et al. Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science. 2010;330(6012):1774.
    • (2010) Science , vol.330 , Issue.6012 , pp. 1774
    • Mawuenyega, K.G.1    Sigurdson, W.2    Ovod, V.3
  • 60
    • 39749182234 scopus 로고    scopus 로고
    • Apoptosis: Controlled demolition at the cellular level
    • Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol. 2008;9(3):231–241.
    • (2008) Nat Rev Mol Cell Biol , vol.9 , Issue.3 , pp. 231-241
    • Taylor, R.C.1    Cullen, S.P.2    Martin, S.J.3
  • 61
    • 84879780600 scopus 로고    scopus 로고
    • Autophagy: Shaping the tumor microenvironment and therapeutic response
    • Maes H, Rubio N, Garg AD, Agostinis P. Autophagy: shaping the tumor microenvironment and therapeutic response. Trends Mol Med. 2013; 19(7):428–446.
    • (2013) Trends Mol Med , vol.19 , Issue.7 , pp. 428-446
    • Maes, H.1    Rubio, N.2    Garg, A.D.3    Agostinis, P.4
  • 62
    • 0034537290 scopus 로고    scopus 로고
    • Autophagy as a regulated pathway of cellular degradation
    • Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290(5497):1717–1721.
    • (2000) Science , vol.290 , Issue.5497 , pp. 1717-1721
    • Klionsky, D.J.1    Emr, S.D.2
  • 63
    • 84890117063 scopus 로고    scopus 로고
    • Melatonin-enhanced autophagy protects against neural apoptosis via a mitochondrial pathway in early brain injury following a subarachnoid hemorrhage
    • Chen J, Wang L, Wu C, et al. Melatonin-enhanced autophagy protects against neural apoptosis via a mitochondrial pathway in early brain injury following a subarachnoid hemorrhage. J Pineal Res. 2014;56(1): 12–19.
    • (2014) J Pineal Res , vol.56 , Issue.1 , pp. 12-19
    • Chen, J.1    Wang, L.2    Wu, C.3
  • 64
    • 84903276737 scopus 로고    scopus 로고
    • Abeta, oxidative stress in Alzheimer disease: Evidence based on proteomics studies
    • Swomley AM, Förster S, Keeney JT, et al. Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. Biochim Biophys Acta. 2014;1842(8):1248–1257.
    • (2014) Biochim Biophys Acta , vol.1842 , Issue.8 , pp. 1248-1257
    • Swomley, A.M.1    Förster, S.2    Keeney, J.T.3
  • 65
    • 84903304059 scopus 로고    scopus 로고
    • Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease
    • Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta. 2014;1842(8):1240–1247.
    • (2014) Biochim Biophys Acta , vol.1842 , Issue.8 , pp. 1240-1247
    • Wang, X.1    Wang, W.2    Li, L.3    Perry, G.4    Lee, H.G.5    Zhu, X.6
  • 66
    • 58149374037 scopus 로고    scopus 로고
    • Antioxidant Therapy in Alzheimer’s Disease: Theory and Practice
    • Aliev G, Obrenovich ME, Reddy VP, et al. Antioxidant Therapy in Alzheimer’s Disease: Theory and Practice. Mini Rev Med Chem. 2008;8(13):1395–1406.
    • (2008) Mini Rev Med Chem , vol.8 , Issue.13 , pp. 1395-1406
    • Aliev, G.1    Obrenovich, M.E.2    Reddy, V.P.3
  • 67
    • 84878572136 scopus 로고    scopus 로고
    • Toward clinical application of the Keap1-Nrf2 pathway
    • Suzuki T, Motohashi H, Yamamoto M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci. 2013;34(6):340–346.
    • (2013) Trends Pharmacol Sci , vol.34 , Issue.6 , pp. 340-346
    • Suzuki, T.1    Motohashi, H.2    Yamamoto, M.3
  • 68
    • 84867034260 scopus 로고    scopus 로고
    • Role of nrf2 in oxidative stress and toxicity
    • Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401–426.
    • (2013) Annu Rev Pharmacol Toxicol , vol.53 , pp. 401-426
    • Ma, Q.1
  • 69
    • 84896817308 scopus 로고    scopus 로고
    • Dysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases
    • Purro SA, Galli S, Salinas PC. Dysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases. J Mol Cell Biol. 2014;6(1):75–80.
    • (2014) J Mol Cell Biol , vol.6 , Issue.1 , pp. 75-80
    • Purro, S.A.1    Galli, S.2    Salinas, P.C.3
  • 70
    • 84872587279 scopus 로고    scopus 로고
    • GSK3 and Tau: Two convergence points in Alzheimer’s disease
    • Hernandez F, Lucas JJ, Avila J. GSK3 and Tau: two convergence points in Alzheimer’s disease. J Alzheimers Dis. 2013;33 Suppl 1: S141–S144.
    • (2013) J Alzheimers Dis , vol.33 , pp. S141-S144
    • Hernandez, F.1    Lucas, J.J.2    Avila, J.3
  • 71
    • 58849083195 scopus 로고    scopus 로고
    • Midlife coffee and tea drinking and the risk of late-life dementia: A population-based CAIDE study
    • Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis. 2009;16(1): 85–91.
    • (2009) J Alzheimers Dis , vol.16 , Issue.1 , pp. 85-91
    • Eskelinen, M.H.1    Ngandu, T.2    Tuomilehto, J.3    Soininen, H.4    Kivipelto, M.5
  • 72
    • 77956203395 scopus 로고    scopus 로고
    • Caffeine intake and dementia: Systematic review and meta-analysis
    • Santos C, Costa J, Santos J, Vaz-Carneiro A, Lunet N. Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis. 2010;20 Suppl 1:S187–S204.
    • (2010) J Alzheimers Dis , vol.20 , pp. S187-S204
    • Santos, C.1    Costa, J.2    Santos, J.3    Vaz-Carneiro, A.4    Lunet, N.5
  • 73
    • 0029742199 scopus 로고    scopus 로고
    • Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice
    • Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274(5284):99–102.
    • (1996) Science , vol.274 , Issue.5284 , pp. 99-102
    • Hsiao, K.1    Chapman, P.2    Nilsen, S.3
  • 74
    • 44349184966 scopus 로고    scopus 로고
    • Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production
    • Shimizu H, Tosaki A, Kaneko K, Hisano T, Sakurai T, Nukina N. Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production. Mol Cell Biol. 2008;28(11): 3663–3671.
    • (2008) Mol cell Biol , vol.28 , Issue.11 , pp. 3663-3671
    • Shimizu, H.1    Tosaki, A.2    Kaneko, K.3    Hisano, T.4    Sakurai, T.5    Nukina, N.6
  • 75
    • 1942470549 scopus 로고    scopus 로고
    • Flap position of free memapsin 2 (beta-secretase), a model for flap opening in aspartic protease catalysis
    • Hong L, Tang J. Flap position of free memapsin 2 (beta-secretase), a model for flap opening in aspartic protease catalysis. Biochemistry. 2004;43(16):4689–4695.
    • (2004) Biochemistry , vol.43 , Issue.16 , pp. 4689-4695
    • Hong, L.1    Tang, J.2
  • 76
    • 84879067500 scopus 로고    scopus 로고
    • Structure-based design of β-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease
    • Yuan J, Venkatraman S, Zheng Y, McKeever BM, Dillard LW, Singh SB. Structure-based design of β-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease. J Med Chem. 2013; 56(11):4156–4180.
    • (2013) J Med Chem , vol.56 , Issue.11 , pp. 4156-4180
    • Yuan, J.1    Venkatraman, S.2    Zheng, Y.3    McKeever, B.M.4    Dillard, L.W.5    Singh, L.6
  • 77
    • 85027929889 scopus 로고    scopus 로고
    • Aβ oligomer-induced synapse degeneration in Alzheimer’s disease
    • Wilcox KC, Lacor PN, Pitt J, Klein WL. Aβ oligomer-induced synapse degeneration in Alzheimer’s disease. Cell Mol Neurobiol. 2011;31(6): 939–948.
    • (2011) Cell Mol Neurobiol , vol.31 , Issue.6 , pp. 939-948
    • Wilcox, K.C.1    Lacor, P.N.2    Pitt, J.3    Klein, W.L.4
  • 78
    • 84857642949 scopus 로고    scopus 로고
    • The toxic Aβ oligomer and Alzheimer’s disease: An emperor in need of clothes
    • Benilova I, Karran E, De Strooper B. The toxic Aβ oligomer and Alzheimer’s disease: an emperor in need of clothes. Nat Neurosci. 2012; 15(3):349–357.
    • (2012) Nat Neurosci , vol.15 , Issue.3 , pp. 349-357
    • Benilova, I.1    Karran, E.2    De Strooper, B.3
  • 79
    • 77951776829 scopus 로고    scopus 로고
    • Alzheimer’s disease: Strategies for disease modification
    • Citron M. Alzheimer’s disease: strategies for disease modification. Nat Rev Drug Discov. 2010;9(5):387–398.
    • (2010) Nat Rev Drug Discov , vol.9 , Issue.5 , pp. 387-398
    • Citron, M.1
  • 80
    • 84872552899 scopus 로고    scopus 로고
    • Synaptotoxic amyloid-β oligomers: A molecular basis for the cause, diagnosis, and treatment of Alzheimer’s disease?
    • Klein WL. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer’s disease? J Alzheimers Dis. 2013;33 Suppl 1:S49–S65.
    • (2013) J Alzheimers Dis , vol.33 , pp. S49-S65
    • Klein, W.L.1
  • 81
    • 27644493692 scopus 로고    scopus 로고
    • Globular amyloid betapeptide oligomer – a homogenous and stable neuropathological protein in Alzheimer’s disease
    • Barghorn S, Nimmrich V, Striebinger A, et al. Globular amyloid betapeptide oligomer – a homogenous and stable neuropathological protein in Alzheimer’s disease. J Neurochem. 2005;95(3):834–847.
    • (2005) J Neurochem , vol.95 , Issue.3 , pp. 834-847
    • Barghorn, S.1    Nimmrich, V.2    Striebinger, A.3
  • 82
    • 0042838303 scopus 로고    scopus 로고
    • Alzheimer’s disease-affected brain: Presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss
    • Gong Y, Chang L, Viola KL, et al. Alzheimer’s disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A. 2003; 100(18):10417–10422.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , Issue.18 , pp. 10417-10422
    • Gong, Y.1    Chang, L.2    Viola, K.L.3
  • 83
    • 0035846613 scopus 로고    scopus 로고
    • Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide
    • Poeggeler B, Miravalle L, Zagorski MG, et al. Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide. Biochemistry. 2001;40(49):14995–15001.
    • (2001) Biochemistry , vol.40 , Issue.49 , pp. 14995-15001
    • Poeggeler, B.1    Miravalle, L.2    Zagorski, M.G.3
  • 84
    • 48449102539 scopus 로고    scopus 로고
    • The neuroprotective role of melatonin against amyloid beta peptide injected mice
    • Masilamoni JG, Jesudason EP, Dhandayuthapani S, et al. The neuroprotective role of melatonin against amyloid beta peptide injected mice. Free Radic Res. 2008;42(7):661–673.
    • (2008) Free Radic Res , vol.42 , Issue.7 , pp. 661-673
    • Masilamoni, J.G.1    Jesudason, E.P.2    Dhandayuthapani, S.3
  • 85
    • 77954537925 scopus 로고    scopus 로고
    • Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline
    • Cunha RA, Agostinho PM. Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J Alzheimers Dis. 2010;20 Suppl 1:S95–S116.
    • (2010) J Alzheimers Dis , vol.20 , pp. SS95-S116
    • Cunha, R.A.1    Agostinho, P.M.2
  • 86
    • 1842759592 scopus 로고    scopus 로고
    • Melatonin attenuates beta-amyloid-induced inhibition of neurofilament expression
    • Zhang YC, Wang ZF, Wang Q, Wang YP, Wang JZ. Melatonin attenuates beta-amyloid-induced inhibition of neurofilament expression. Acta Pharmacol Sin. 2004;25(4):447–451.
    • (2004) Acta Pharmacol Sin , vol.25 , Issue.4 , pp. 447-451
    • Zhang, Y.C.1    Wang, Z.F.2    Wang, Q.3    Wang, Y.P.4    Wang, J.Z.5
  • 87
    • 42149135452 scopus 로고    scopus 로고
    • Effect of melatonin and melatonylvalpromide on betaamyloid and neurofilaments in N2a cells
    • Wang XC, Zhang YC, Chatterjie N, Grundke-Iqbal I, Iqbal K, Wang JZ. Effect of melatonin and melatonylvalpromide on betaamyloid and neurofilaments in N2a cells. Neurochem Res. 2008; 33(6):1138–1144.
    • (2008) Neurochem Res , vol.33 , Issue.6 , pp. 1138-1144
    • Wang, X.C.1    Zhang, Y.C.2    Chatterjie, N.3    Grundke-Iqbal, I.4    Iqbal, K.5    Wang, J.Z.6
  • 88
    • 84897012511 scopus 로고    scopus 로고
    • From epidemiology to pathophysiology: What about caffeine in Alzheimer’s disease?
    • Flaten V, Laurent C, Coelho JE, et al. From epidemiology to pathophysiology: what about caffeine in Alzheimer’s disease? Biochem Soc Trans. 2014;42(2):587–592.
    • (2014) Biochem Soc Trans , vol.42 , Issue.2 , pp. 587-592
    • Flaten, V.1    Laurent, C.2    Coelho, J.E.3
  • 89
    • 84902082985 scopus 로고    scopus 로고
    • Beneficial effects of caffeine in a transgenic model of Alzheimer’s disease-like Tau pathology
    • Laurent C, Eddarkaoui S, Derisbourg M, et al. Beneficial effects of caffeine in a transgenic model of Alzheimer’s disease-like Tau pathology. Neurobiol Aging. 2014;35(9):2079–2090.
    • (2014) Neurobiol Aging , vol.35 , Issue.9 , pp. 2079-2090
    • Laurent, C.1    Eddarkaoui, S.2    Derisbourg, M.3
  • 90
    • 84888062913 scopus 로고    scopus 로고
    • Epidemiology and etiology of Alzheimer’s disease: From genetic to non-genetic factors
    • Jiang T, Yu JT, Tian Y, Tan L. Epidemiology and etiology of Alzheimer’s disease: from genetic to non-genetic factors. Curr Alzheimer Res. 2013;10(8):852–867.
    • (2013) Curr Alzheimer Res , vol.10 , Issue.8 , pp. 852-867
    • Jiang, T.1    Yu, J.T.2    Tian, Y.3    Tan, L.4
  • 91
    • 77953823903 scopus 로고    scopus 로고
    • The circadian expression of c-MYC is modulated by the histone deacetylase inhibitor trichostatin A in synchronized murine neuroblastoma cells
    • Repouskou A, Sourlingas TG, Sekeri-Pataryas KE, Prombona A. The circadian expression of c-MYC is modulated by the histone deacetylase inhibitor trichostatin A in synchronized murine neuroblastoma cells. Chronobiol Int. 2010;27(4):722–741.
    • (2010) Chronobiol Int , vol.27 , Issue.4 , pp. 722-741
    • Repouskou, A.1    Sourlingas, T.G.2    Sekeri-Pataryas, K.E.3    Prombona, A.4
  • 92
    • 0041817939 scopus 로고    scopus 로고
    • Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia
    • Asayama K, Yamadera H, Ito T, Suzuki H, Kudo Y, Endo S. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J Nippon Med Sch. 2003;70(4):334–341.
    • (2003) J Nippon Med Sch , vol.70 , Issue.4 , pp. 334-341
    • Asayama, K.1    Yamadera, H.2    Ito, T.3    Suzuki, H.4    Kudo, Y.5    Endo, S.6
  • 93
    • 53749088028 scopus 로고    scopus 로고
    • Nuclear factor erythroid 2-related factor 2 protects against beta amyloid
    • Kanninen K, Malm TM, Jyrkkänen HK, et al. Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol Cell Neurosci. 2008;39(3):302–313.
    • (2008) Mol Cell Neurosci , vol.39 , Issue.3 , pp. 302-313
    • Kanninen, K.1    Malm, T.M.2    Jyrkkänen, H.K.3
  • 94
    • 84897093101 scopus 로고    scopus 로고
    • Nrf2 reduces levels of phosphorylated Tau protein by inducing autophagy adaptor protein NDP52
    • Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GV. Nrf2 reduces levels of phosphorylated Tau protein by inducing autophagy adaptor protein NDP52. Nat Commun. 2014;5:3496.
    • (2014) Nat Commun , vol.5 , pp. 3496
    • Jo, C.1    Gundemir, S.2    Pritchard, S.3    Jin, Y.N.4    Rahman, I.5    Johnson, G.V.6
  • 95
    • 84902578456 scopus 로고    scopus 로고
    • Nrf2 regulates neurogenesis and protects neural progenitor cells against Aβ toxicity
    • Kärkkäinen V, Pomeshchik Y, Savchenko E, et al. Nrf2 regulates neurogenesis and protects neural progenitor cells against Aβ toxicity. Stem Cells. 2014;32(7):1904–1916.
    • (2014) Stem Cells , vol.32 , Issue.7 , pp. 1904-1916
    • Kärkkäinen, V.1    Pomeshchik, Y.2    Savchenko, E.3
  • 96
    • 77951543964 scopus 로고    scopus 로고
    • Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson’s disease through an NRF2-dependent mechanism
    • Trinh K, Andrews L, Krause J, et al. Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson’s disease through an NRF2-dependent mechanism. J Neurosci. 2010;30(16):5525–5532.
    • (2010) J Neurosci , vol.30 , Issue.16 , pp. 5525-5532
    • Trinh, K.1    Andrews, L.2    Krause, J.3
  • 97
    • 84907808578 scopus 로고    scopus 로고
    • Melatonin: Functions and ligands
    • Singh M, Jadhav HR. Melatonin: functions and ligands. Drug Discov Today. 2014;19(9):1410–1418.
    • (2014) Drug Discov Today , vol.19 , Issue.9 , pp. 1410-1418
    • Singh, M.1    Jadhav, H.R.2
  • 98
    • 84901362118 scopus 로고    scopus 로고
    • Effects of melatonin on oxidative stress, and resistance to bacterial, parasitic, and viral infections: A review
    • Vielma JR, Bonilla E, Chacín-Bonilla L, Mora M, Medina-Leendertz S, Bravo Y. Effects of melatonin on oxidative stress, and resistance to bacterial, parasitic, and viral infections: a review. Acta Trop. 2014;137: 31–38.
    • (2014) Acta Trop , vol.137 , pp. 31-38
    • Vielma, J.R.1    Bonilla, E.2    Chacín-Bonilla, L.3    Mora, M.4    Medina-Leendertz, S.5    Bravo, Y.6
  • 99
    • 84904577101 scopus 로고    scopus 로고
    • Ginsenoside Rd attenuates Tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after transient forebrain ischemia
    • Zhang X, Shi M, Ye R, et al. Ginsenoside Rd attenuates Tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after transient forebrain ischemia. Neurochem Res. 2014;39(7):1363–1373.
    • (2014) Neurochem Res , vol.39 , Issue.7 , pp. 1363-1373
    • Zhang, X.1    Shi, M.2    Ye, R.3
  • 101
    • 84885947482 scopus 로고    scopus 로고
    • Parkinson’s disease-associated DJ-1 mutations increase abnormal phosphorylation of Tau protein through Akt/GSK-3β pathways
    • Wang Y, Liu W, He X, Zhou F. Parkinson’s disease-associated DJ-1 mutations increase abnormal phosphorylation of Tau protein through Akt/GSK-3β pathways. J Mol Neurosci. 2013;51(3):911–918.
    • (2013) J Mol Neurosci , vol.51 , Issue.3 , pp. 911-918
    • Wang, Y.1    Liu, W.2    He, X.3    Zhou, F.4
  • 102
    • 84893541699 scopus 로고    scopus 로고
    • The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer’s disease
    • Lynch MA. The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer’s disease. Immunology. 2014;141(3):292–301.
    • (2014) Immunology , vol.141 , Issue.3 , pp. 292-301
    • Lynch, M.A.1
  • 103
    • 84881481931 scopus 로고    scopus 로고
    • Neuronal autophagy: Self-eating or self-cannibalism in Alzheimer’s disease
    • Ułamek-Kozioł M, Furmaga-Jabłońska W, Januszewski S, et al. Neuronal autophagy: self-eating or self-cannibalism in Alzheimer’s disease. Neurochem Res. 2013;38(9):1769–1773.
    • (2013) Neurochem Res , vol.38 , Issue.9 , pp. 1769-1773
    • Ułamek-Kozioł, M.1    Furmaga-Jabłońska, W.2    Januszewski, S.3
  • 104
    • 84882254367 scopus 로고    scopus 로고
    • The role of autophagy in neurodegenerative disease
    • Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19(8):983–997.
    • (2013) Nat Med , vol.19 , Issue.8 , pp. 983-997
    • Nixon, R.A.1
  • 105
    • 84887909793 scopus 로고    scopus 로고
    • Autophagic/lysosomal dysfunction in Alzheimer’s disease
    • Orr ME, Oddo S. Autophagic/lysosomal dysfunction in Alzheimer’s disease. Alzheimers Res Ther. 2013;5(5):53.
    • (2013) Alzheimers Res Ther , vol.5 , Issue.5 , pp. 53
    • Orr, M.E.1    Oddo, S.2
  • 106
    • 84890082542 scopus 로고    scopus 로고
    • Melatonin suppresses nitric oxide production in glial cultures by pro-inflammatory cytokines through p38 MAPK inhibition
    • Vilar A, de Lemos L, Patraca I, et al. Melatonin suppresses nitric oxide production in glial cultures by pro-inflammatory cytokines through p38 MAPK inhibition. Free Radic Res. 2014;48(2):119–128.
    • (2014) Free Radic Res , vol.48 , Issue.2 , pp. 119-128
    • Vilar, A.1    De Lemos, L.2    Patraca, I.3
  • 107
    • 84890280909 scopus 로고    scopus 로고
    • Melatonin modulates microsomal PGE synthase 1 and NF-E2-related factor-2-regulated antioxidant enzyme expression in LPS-induced murine peritoneal macrophages
    • Aparicio-Soto M, Alarcón-de-la-Lastra C, Cárdeno A, Sánchez-Fidalgo S, Sanchez-Hidalgo M. Melatonin modulates microsomal PGE synthase 1 and NF-E2-related factor-2-regulated antioxidant enzyme expression in LPS-induced murine peritoneal macrophages. Br J Pharmacol. 2014;171(1):134–144.
    • (2014) Br J Pharmacol , vol.171 , Issue.1 , pp. 134-144
    • Aparicio-Soto, M.1    Alarcón-De-La-Lastra, C.2    Cárdeno, A.3    Sánchez-Fidalgo, S.4    Sanchez-Hidalgo, M.5
  • 108
    • 85055464242 scopus 로고    scopus 로고
    • Melatonin suppresses markers of inflammation and oxidative damage in a human daytime endotoxemia model
    • Alamili M, Bendtzen K, Lykkesfeldt J, Rosenberg J, Gögenur I. Melatonin suppresses markers of inflammation and oxidative damage in a human daytime endotoxemia model. J Crit Care. 2014;29(1):184.e9–e184.e13.
    • (2014) J Crit Care , vol.29 , Issue.1 , pp. 184.e9-e184.e13
    • Alamili, M.1    Bendtzen, K.2    Lykkesfeldt, J.3    Rosenberg, J.4    Gögenur, I.5
  • 109
    • 84875823973 scopus 로고    scopus 로고
    • Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine
    • Weichelt U, Cay R, Schmitz T, et al. Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine. Eur Respir J. 2013;41(4):966–973.
    • (2013) Eur Respir J , vol.41 , Issue.4 , pp. 966-973
    • Weichelt, U.1    Cay, R.2    Schmitz, T.3
  • 110
    • 84878349327 scopus 로고    scopus 로고
    • Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson’s disease
    • Gołembiowska K, Wardas J, Noworyta-Sokołowska K, Kamiska K, Górska A. Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson’s disease. Neurotox Res. 2013;24(1):29–40.
    • (2013) Neurotox Res , vol.24 , Issue.1 , pp. 29-40
    • Gołembiowska, K.1    Wardas, J.2    Noworyta-Sokołowska, K.3    Kamiska, K.4    Górska, A.5
  • 111
    • 79551508637 scopus 로고    scopus 로고
    • Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition
    • Saiki S, Sasazawa Y, Imamichi Y, et al. Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy. 2011;7(2):176–187.
    • (2011) Autophagy , vol.7 , Issue.2 , pp. 176-187
    • Saiki, S.1    Sasazawa, Y.2    Imamichi, Y.3
  • 112
    • 84896488935 scopus 로고    scopus 로고
    • Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice
    • Sinha RA, Farah BL, Singh BK, et al. Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology. 2014;59(4):1366–1380.
    • (2014) Hepatology , vol.59 , Issue.4 , pp. 1366-1380
    • Sinha, R.A.1    Farah, B.L.2    Singh, B.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.